Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-06

Clinical Trial Update: Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by the National Institute on Drug Abuse evaluating varenicline for tobacco addiction and abstinence-induced cognitive impairment has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Drug Addiction | Phase 1 | Status: WITHDRAWN